taliglucerase alfa

01/01/2012 - "This review considers the existing evidence for therapeutic efficacy of taliglucerase alfa in the treatment of the non-neuronopathic manifestations of Gaucher disease. "
11/01/2018 - "Improvement in bone marrow infiltration in patients with type I Gaucher disease treated with taliglucerase alfa."
01/01/2015 - "Safety and efficacy of two dose levels of taliglucerase alfa in pediatric patients with Gaucher disease."
11/24/2011 - "These results support safety and efficacy of taliglucerase alfa for Gaucher disease."
11/01/2018 - "A larger study is needed to assess the early benefit of taliglucerase alfa in adult patients with type 1 Gaucher disease on the bone marrow compartment."

01/15/2011 - "Abdominal MRI examinations at screening and after 6 and 9 months' exposure to a novel plant-cell-derived recombinant enzyme, taliglucerase alfa, were taken in 31 patients with Gaucher disease and at least 8-fold greater than expected splenomegaly. "

07/01/2012 - "Tazarotene (Fabior Foam) for acne; estradiol valerate and estradiol valerate/dienogest (Natazia) for heavy menstrual bleeding; and taliglucerase alfa (Elelyso) for Gaucher's disease."

01/01/2012 - "Taliglucerase alfa has shown a good safety profile, with few patients experiencing hypersensitivity reactions and developing antibodies. "

12/01/2014 - "Patients with stable disease were offered taliglucerase alfa treatment using the same dose (9-60U/kg body weight) and regimen of administration (every 2weeks) as imiglucerase. "